Rituximab therapy for hepatitis C virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis

Membranoproliferative glomerulonephritis associated with mixed cryoglobulinemia is the most common form of kidney disease observed in relation to hepatitis C virus (HCV) infection. Rituximab, a monoclonal antibody against CD20, is an effective treatment for severe and/or refractory HCV‐related vascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Koratala, Abhilash, Zeng, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799646/
https://www.ncbi.nlm.nih.gov/pubmed/29445495
http://dx.doi.org/10.1002/ccr3.1371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799646/
https://www.ncbi.nlm.nih.gov/pubmed/29445495
http://dx.doi.org/10.1002/ccr3.1371

Ejemplares similares